Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Sarcoma, Synovial 1 Sarcoma 1 Non-Small Cell Lung Cancer Metastatic 1 Neurofibrosarcoma 1 Melanoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Esophageal Neoplasms 1 Dermatofibrosarcoma 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1

Interventions

HhAntag691 25 Imiquimod 12 Biopsy 12 sonidegib 11 Aminolevulinic Acid 9 cemiplimab 8 Photochemotherapy 8 Nivolumab 8 methyl 5-aminolevulinate 7 Mohs Surgery 7 1-phenyl-3,3-dimethyltriazene 7 Tomography, Optical Coherence 6 Surgical Procedures, Operative 6 Specimen Handling 5 Radiotherapy 5 Itraconazole 5 pembrolizumab 4 daromun 4 Microscopy, Confocal 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 Curettage 4 Standard of Care 3 Niacinamide 3 IPI-926 3 CTLA-4 Antigen 3 3-ingenyl angelate 3 tazarotene 2 talimogene laherparepvec 2 relatlimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × BO-112 × Clear all

NCT06422936 2026-01-26

SPOTLIGHT204

Highlight Therapeutics

Phase 2 Active not recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡